Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes

Inclusion Criteria

• •1. Age in the range of 18-70 years.
• •2. Patients with T2DM, diagnosed at least 6 months prior to Visit 1, who have received metformin for at least 3 months and have been on a stable dose of at least 1000mg daily for a minimum of 4 weeks prior to Visit 1.
• •3. HbA1c ≤ 7.6% at Visit 1.
• •4. Body mass index (BMI) in the range of 22-38kg/m2 inclusive at Visit 1.